Current evidence for safety and efficacy of anti-programmed cell-death 1 agents in the treatment of cutaneous squamous cell carcinoma: A systematic review

J Am Acad Dermatol. 2020 Feb;82(2):522-524. doi: 10.1016/j.jaad.2019.09.044. Epub 2019 Sep 26.
No abstract available

Publication types

  • Letter
  • Systematic Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell / drug therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors*
  • Skin Neoplasms / drug therapy*
  • Treatment Outcome
  • Young Adult

Substances

  • Programmed Cell Death 1 Receptor